Showing 4001-4020 of 7110 for: Cochrane Systematic Reviews Back
- Melatonin as add-on treatment for epilepsy
Cochrane Systematic Reviews, 17-Mar-2016
This is an updated version of the original Cochrane review published in Issue 6, 2012.
- Melatonin for non-respiratory sleep disorders in visually impaired children
Cochrane Systematic Reviews, 3-Oct-2011
Exogenous melatonin helps in regulating the circadian rhythm and is widely used for the management of sleep disorders in visually impaired children.
- Melatonin for pre- and postoperative anxiety in adults
Cochrane Systematic Reviews, 9-Apr-2015
Anxiety in relation to surgery is a well-known problem. Melatonin offers an atoxic alternative to benzodiazepines in ameliorating this condition in the pre- and postoperative period.
- Melatonin for the prevention and treatment of jet lag
Cochrane Systematic Reviews, 3-Mar-2009
Jet lag commonly affects air travellers who cross several time zones. It results from the body's internal rhythms being out of step with the day-night cycle at the destination. Melatonin is a pineal hormone that plays a central part in regulating bodily r
- Melatonin for the treatment of dementia
Cochrane Systematic Reviews, 16-Feb-2011
There are a number of studies that suggest a relationship between decline of melatonin function and the symptoms of dementia.
- Memantine for autism spectrum disorder
Cochrane Systematic Reviews, 25-Aug-2022
Autism spectrum disorder (ASD; also known as autism) is a developmental disability that begins in childhood and is typically seen in around 1% to 2% of children. It is characterised by social communication difficulties and repetitive and restricted behavi
- Memantine for dementia
Cochrane Systematic Reviews, 3-Nov-2008
Memantine, a low affinity antagonist to glutamate NMDA receptors, may prevent excitatory neurotoxicity in dementia.
- Memantine for dementia in people with Down syndrome
Cochrane Systematic Reviews, 18-Nov-2008
Alzheimer's dementia (AD) is the most common form of dementia in people with Down Syndrome (DS). There is an understanding that an increase in L-glutamate contributes to the pathogenesis of cerebral ischemias and AD. Memantine acts as an antagonist of N-m
- Membrane sweeping for induction of labour
Cochrane Systematic Reviews, 26-Aug-2009
Sweeping of the membranes, also named stripping of the membranes, is a relatively simple technique usually performed without admission to hospital. During vaginal examination, the clinician's finger is introduced into the cervical os. Then, the inferior p
- Memory rehabilitation for people with multiple sclerosis
Cochrane Systematic Reviews, 18-Oct-2021
Problems with cognition, particularly memory, are common in people with multiple sclerosis (MS) and can affect their ability to complete daily activities and can negatively affect quality of life. Over the last few years, there has been considerable growt
- Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women
Cochrane Systematic Reviews, 26-Jul-2022
Ovarian cancer (OC) has the highest case fatality rate of all gynaecological cancers. Diagnostic delays are caused by non-specific symptoms. Existing systematic reviews have not comprehensively covered tests in current practice, not estimated accuracy sep
- Mental practice for treating upper extremity deficits in individuals with hemiparesis after stroke
Cochrane Systematic Reviews, 21-Jun-2011
Activity limitations of the upper extremity are a common finding for individuals living with stroke. Mental practice (MP) is a training method that uses cognitive rehearsal of activities to improve performance of those activities.
- Mentoring adolescents to prevent drug and alcohol use
Cochrane Systematic Reviews, 5-Sep-2011
Many adolescents receive mentoring. There is no systematic review if mentoring prevents alcohol and drug use.
- Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition
Cochrane Systematic Reviews, 30-Jan-2019
Recipients of allogeneic haematopoietic stem cell transplants (HSCT) can develop acute or chronic, or both forms of graft-versus-host disease (a/cGvHD), whereby immune cells of the donor attack host tissues. Steroids are the primary treatment, but patient
- Metal protein attenuating compounds for the treatment of Alzheimer's dementia
Cochrane Systematic Reviews, 20-Feb-2014
Alzheimer's dementia (AD) may be caused by the formation of extracellular senile plaques comprised of beta-amyloid (Aß). In vitro and mouse model studies have demonstrated that metal protein attenuating compounds (MPACs) promote the solubilisation and cle
- Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates
Cochrane Systematic Reviews, 30-Oct-2008
Metalloporphyrins are heme analogues that inhibit heme oxygenase, the rate-limiting enzyme in the catabolism of heme to bilirubin. By preventing the formation of bilirubin, they have the potential to reduce the level of unconjugated bilirubin in neonates
- Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving mechanical ventilation in critical care units
Cochrane Systematic Reviews, 30-Apr-2013
Nebulizers and metered dose inhalers (MDI) have both been adapted for delivering aerosol bronchodilation to mechanically ventilated patients, but there is incomplete knowledge as to the most effective method of delivery.
- Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents
Cochrane Systematic Reviews, 10-Nov-2008
In adolescents with type 1 diabetes, insulin resistance likely plays a role in the deterioration of metabolic control. In type 1 diabetes, addition of metformin to insulin therapy, to improve insulin sensitivity, has been assessed in a few trials involvin
- Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes
Cochrane Systematic Reviews, 24-Jul-2018
There has been considerable interest in providing antenatal dietary and lifestyle advice for women with obesity or who are overweight during pregnancy, as a strategy to limit gestational weight gain and improve maternal and infant health. However, such an
- Metformin monotherapy for type 2 diabetes mellitus
Cochrane Systematic Reviews, 30-Sep-2015
Metformin is an anti-hyperglycaemic agent used for the treatment of type 2 diabetes mellitus. Type 2 diabetes may present long-term complications: micro- (retinopathy, nephropathy and neuropathy) and macrovascular (stroke, myocardial infarction and periph
